Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03752684 · ClinicalTrials.gov registry record · NA
Oxalobacter Formigenes Colonization and Urinary Oxalate Excretion
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT03752684 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 26 participants.
The verdict
NCT03752684, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this research study is to assess the efficacy of ingesting a small amount of the harmless bacterium Oxalobacter formigenes in establishing residence in the guts of healthy participants and to determine whether this influences the oxalate passed in urine.
Interventions
- DIETARY_SUPPLEMENT Moderately high oxalate/low calcium diet non-colonized
- DIETARY_SUPPLEMENT Oxalobacter formigenes
- DIETARY_SUPPLEMENT Moderately high oxalate/low calcium diet colonized
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2018-04-02 |
| Est. Completion | 2025-05-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03752684
The ClinicalTrials.gov registry entry for NCT03752684 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Moderately high oxalate/low calcium diet non-colonized is the first listed.
NCT03752684 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03752684 about?
NCT03752684 is a clinical study titled "Oxalobacter Formigenes Colonization and Urinary Oxalate Excretion". The purpose of this research study is to assess the efficacy of ingesting a small amount of the harmless bacterium Oxalobacter formigenes in establishing residence in the guts of healthy participants and to determine whether this influences the oxalate passed in urine.
What is the current status of trial NCT03752684?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2018-04-02. Estimated completion is 2025-05-22.
What interventions are being tested in trial NCT03752684?
The interventions under investigation include: Moderately high oxalate/low calcium diet non-colonized (DIETARY_SUPPLEMENT), Oxalobacter formigenes (DIETARY_SUPPLEMENT), Moderately high oxalate/low calcium diet colonized (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03752684?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.